“…1 More rarely, PLC may be seen as a paraneoplastic phenomenon or a reaction to a medication. 3 , 4 Some researchers label PLC as a lymphoproliferative disorder given that these patients have demonstrated T-cell clonality, but this is highly debated in the literature. 1 , 2 , 5 Herein, we present a case of PLC in a patient with diffuse large B-cell lymphoma (DLBCL) who developed a rash after initiating tafasitamab/lenalidomide therapy.…”